In the METABRIC cohort, the PD-1 expression level was also an independent prognostic indicator for breast cancer after adjusting for tumor grade, AJCC stage, ER, PR, and HER2 status (Figure 8B). This evidence concerns the gene ESR1 and breast carcinoma.